SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Aduro Biotech, Inc. (ADRO) and Encourages Investors to Contact the Firm

PHILADELPHIA, PA / ACCESSWIRE / June 18, 2020 / Kaskela Law LLC announces that it is investigating Aduro Biotech, Inc. ("Aduro Biotech") (NASDAQ:ADRO) on behalf of the company's shareholders.

The investigation seeks to determine whether the company's officers and/or directors have violated the securities laws or breached their fiduciary duties to shareholders in connection with recent actions, causing injury to Aduro Biotech and its shareholders.

Aduro Biotech shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 – 1585, or by email at skaskela@kaskelalaw.com or online at http://kaskelalaw.com/case/aduro-biotech-inc/, for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Boulevard, Suite 100
Newtown Square, PA 19073
(484) 258 – 1585
(888) 715 – 1740
www.kaskelalaw.com
skaskela@kaskelalaw.com

SOURCE: Kaskela Law LLC

ReleaseID: 594294